Just a moment, the page is loading...
Browse ALL STUDIES
Keyword Search
View All Selected
Clear All
Login / Create Account
Login
Create Account
Home
About Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Data Sponsors
Researchers
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
Help/Contact Us
IMPROVING METHODS. Our research focus is to optimize the translation of clinical trial results into clinical practice.
Proposal
1540
Title of Proposed Research
IMPROVING METHODS. Our research focus is to optimize the translation of clinical trial results into clinical practice.
Lead Researcher
Dr. Issa Dahabreh
Affiliation
Brown University
Funding Source
PCORI
Potential Conflicts of Interest
None
Data Sharing Agreement Date
16 September 2016
Lay Summary
Our research focus is to optimize the translation of clinical trial results into clinical practice. By leveraging advances in causal inference and considerable existing data resources we will achieve the following specific aims. Our first aim is to develop methods for assessing the applicability of RCTs and transporting causal effects from RCTs to target populations; describe methods for assessing the robustness of inferences based on these methods. Second, to evaluate the performance of methods developed in Aim 1 in simulation studies that will reflect real-world data. Third, to empirically assess the methods developed under Aims 1 and 2 in high-impact clinical topics (including the ALLHAT trial). Our methods will allow decision-makers to (1) statistically assess the applicability of trials to a target population; (2) “transport” trial results to patients seen in clinical practice; (3) apply trial results to specific patient subgroups in the broader target population.
Study Data Provided
[{ "PostingID": 48, "Title": "GSK-AR1108888", "Description": "FondaparinUx Trial with Unfractionated Heparin (UFH) during Revascularization in Acute Coronary Syndromes (ACS) (FUTURA). A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with Unstable Angina/Non ST segment elevation myocardial infarction (UA/NSTEMI) initially treated with subcutaneous fondaparinux and referred for early coronary angiography (OASIS 8)
Medicine: fondaparinux sodium, Condition: Acute Coronary Syndrome, Phase: 4, Clinic" }]
Statistical Analysis Plan
The statistical analysis plan will be added after the research is published.
Publication Citation
The publication citation will be added after the research is published.
© 2025 ideaPoint. All Rights Reserved.
Powered by ideaPoint.
Help
Privacy Policy
Cookie Policy
Help and Resources